The Impact of Inflammation and Immune Activation on B Cell Differentiation during HIV-1 Infection by Nicolas Ruffin et al.
PERSPECTIVE ARTICLE
published: 05 January 2012
doi: 10.3389/ﬁmmu.2011.00090
The impact of inﬂammation and immune activation on
B cell differentiation during HIV-1 infection
Nicolas Rufﬁn1, Pham HongThang1,2, Bence Rethi 1, Anna Nilsson1,3 and Francesca Chiodi 1*
1 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
2 Department of HIV/AIDS, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
3 Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Edited by:
Frank Kirchhoff, University Clinic Ulm,
Germany
Reviewed by:
Jan Muench, Ulm University,
Germany
Michael Schindler, Helmholtz Zentrum
München, Germany
Andrea Cossarizza, University of
Modena and Reggio Emilia, Italy
*Correspondence:
Francesca Chiodi , Department of
Microbiology, Tumor and Cell Biology,
Karolinska Institutet, Nobelsväg 16,
S-17177 Stockholm, Sweden.
e-mail: francesca.chiodi@ki.se
One important pathogenic feature of human immunodeﬁciency virus (HIV)-1 infection is
chronic immune activation and impaired survival ofT and B cells. A decline of resting mem-
ory B cells was reported to occur in both children and adults infected with HIV-1; these
cells are responsible for maintaining an adequate serological response to antigens previ-
ously encountered in life through natural infection or vaccination. Further understanding
of the mechanisms leading to impaired B cell differentiation and germinal center reaction
might be essential to design new HIV vaccines and therapies that could improve humoral
immune responses in HIV-1 infected individuals. In the present article we summarize the
literature and present our view on critical mechanisms of B cell development impaired dur-
ing HIV-1 infection. We also discuss the impact of microbial translocation, a driving force
for persistent inﬂammation during HIV-1 infection, on survival of terminally differentiated B
cells and how the altered expression of cytokines/chemokines pivotal for communication
betweenT and B cells in lymphoid tissues may impair formation of memory B cells.
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INTRODUCTION
Human immunodeﬁciency virus (HIV)-1 infection is accompa-
nied by weakened humoral responses to pathogens and vaccina-
tion antigens, which are not fully restored upon anti-retroviral
therapy (ART; Titanji et al., 2006; Cagigi et al., 2010; Geretti and
Doyle, 2010). Adaptive immunity has the unique capacity to con-
fer memory to the immune system, leading to faster and stronger
responses to recall antigens;memoryB cells andplasma cells (PCs),
leaving in specialized niches within the spleen and bone marrow
(BM) are responsible for antibody secretion several years after vac-
cination and natural infections (Lanzavecchia and Sallusto, 2009).
Early studies showed an abnormal activation of B cells isolated
from HIV-1 infected patients, resulting in increased concentration
of circulating immunoglobulin G (IgG), a phenomenon known as
hypergammaglobulinemia (Lane et al., 1983). Peripheral blood B
cells from HIV-1 infected individuals are also susceptible to apop-
tosis (Muro-Cacho et al., 1995; Samuelsson et al., 1997) and show
signs of exhaustion (Moir et al., 2001, 2008). In the lymphoid
compartment of HIV-1 infected patients, accumulation of PCs
was observed (Macias et al., 2001; Alos et al., 2005), possibly also
accounting for hypergammaglobulinemia measured in serum. A
role for HIV-1 virion and proteins in B cell activation has been
envisaged. TheHIV-1protein gp120was also shown tobind to ton-
silar and splenic B cells and led to their polyclonal activation (He
et al., 2006). Nef appears to mediate multiple and opposite func-
tions. Nef protein expressed on infected macrophages may lead
to production of ferritin, which in turn promoted activation of B
cells (Swingler et al., 2008). However it has also been shown that
Nef suppresses immunoglobulin class-switchDNA recombination
through blocking of CD154 pathway (Qiao et al., 2006).
Human immunodeﬁciency virus-1 infected patients retain the
ability to generate HIV-1 speciﬁc memory B cells with mutated
immunoglobulins (Scheid et al., 2009), suggesting that somatic
hypermutation still occurs at early stage of the disease. Nev-
ertheless, it has been questioned whether long-lived PCs could
be established in HIV-1 infected patients (Lewis, 2010; Mascola
and Monteﬁori, 2010). Indeed, despite high levels of circulating
immunoglobulins (Lane et al., 1983),HIV-1 infected patients have
a reduced number of CD27+ classicalmemoryB cells in blood and
reduced levels of long-term serological memory, deﬁned as circu-
lating antibodies to previously encountered pathogens and vaccine
antigens (Titanji et al., 2006;Cagigi et al., 2010;Chiodi, 2010).Data
from vaccination studies show that early antibody responses are
similar in healthy individuals and HIV-1 infected patients (Ho
et al., 2011). However, several months after vaccination, the lev-
els of speciﬁc antibodies are decreased in patients (Pariani et al.,
2011), suggesting either a defective generation or survival of mem-
ory B cells and PCs. Additionally, a recent study demonstrated
that the levels of total immunoglobulins and HIV-1 neutraliz-
ing antibodies are affected by Rituximab treatment, an anti-CD20
monoclonal antibody which leads to depletion of memory B cells
but not long-lived PCs lacking CD20 expression (Huang et al.,
2010). Hypergammaglobulinemia disappeared transiently follow-
ing B cell depletion and loss of anti-HIV antibodies was associated
with an increase in viral load in this HIV-1 untreated patient. The
effect of Rituximab treatment on the level of non-neutralizingHIV
antibodies was not discussed (Huang et al., 2010).
Altogether, these results support the possibility that high lev-
els of immunoglobulins could preferentially arise from activated
memory B cells and strengthen the hypothesis on the impaired
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differentiation of long-lived PCs during HIV-1 infection, as a
consequence of deﬁcient GC formation. The elucidation of sig-
naling pathways involved in GC formation upon physiological
conditions has just begun. Fragmentary knowledge is available
on how HIV-1 infection perturbs B cell differentiation and GC
formation. This perspective article will focus herein on signaling
pathways important for B cell differentiation and GC formation
that could be altered during HIV-1 infection and represent the
underlying mechanisms for B cell dysfunctions in patients. The
processes of microbial translocation and associated inﬂammation,
taking place during acute and chronic phases of HIV-1 infection
(Miedema, 2011), may strongly inﬂuence B cell homeostasis and
effector functions.
IMPAIRED SEROLOGICAL MEMORY DURING HIV-1: INSIGHT
IN THE GC REACTION
Memory B cells originate from GC-dependent or independent
pathways (Berkowska et al., 2011). The canonical pathway involves
the formation of GC in secondary lymphoid organs. Activated B
cells, known as centroblasts, need to encounter antigen-presenting
cells [dendritic cells,macrophage, follicular dendritic cells (FDC)]
and T follicular helper (Tfh) cells to receive appropriate signals.
Cell to cell contact, as well as chemokines and cytokines are essen-
tial for expansion, selection, and differentiation of Ag-speciﬁc B
cell clones to memory B cells or long-lived PCs (Nutt and Tarlin-
ton, 2011). The differentiation of B cells during HIV-1 infection
may profoundly be affected by T cell depletion, cytokine, and
chemokine alterations (Figure 1) as summarized in the following
paragraphs.
LYMPHOID TISSUE ARCHITECTURE AND T CELL HOMEOSTASIS
The lymphoid tissue is organized to allow the encounter of
immune cellswith antigensunder the regulatory effect of cytokines
and growth factors. Comprising the vast majority of CD4+ T cells,
lymphoid tissue is the place for highHIV-1 replication; as results of
HIV-1 replication and inﬂammation, inﬁltration of effector T cells
into the lymph nodes takes place, followed by chronic immune
activation, which is one of the hallmark of HIV-1 pathogenesis
(Lederman and Margolis, 2008; Van Grevenynghe et al., 2008).
Morphological studies of lymphoid tissues revealed sustained T
cell depletion, lack of lymphoid follicles, and accumulation of PCs
in a majority of patients naïve to treatment (Macias et al., 2001;
Alos et al., 2005). ART, by reducing viral replication, leads to an
increase, but not to normalization, of CD4+ T cells, and the par-
tial restoration of small GCs, although with scarce B cell and FDC
network. The sustained T cell depletion observed in some patients
under ART was associated with collagen deposition in lymphoid
tissues; this lymphatic tissue ﬁbrosis greatly affects the lymph node
architecture (Estes et al., 2008) and possibly also cells and molecu-
lar pathways involved in B cell maturation. Recently, it was shown
that lymphopenia itself can impact maintenance of ﬁbroblastic
reticular cell (FRC) network as these cells require lymphotoxin-β,
a cytokine available at lower concentrations as T cells are depleted.
Since FRCs produce the cytokine IL-7, an essential survival factor
for peripheral T cells, the loss of these cells can lead to a further
decrease in T cell maintenance (Zeng et al., 2011). Loss of lym-
phoid tissue FRC network and associated ﬁbrosis might lead to
an irreversible damage in lymphoid tissue architecture that could
limit immune regenerative therapies.
ALTERED CHEMOKINE EXPRESSION DURING HIV-1 INFECTION
The organization of lymphoid tissues into B and T cell zones is
regulated through the expression of chemokines and chemokine-
receptors. CD4+ helper T cells, after their priming by DCs, can
increase their CXCR5 expression and migrate toward the B cell
zone. Further signals from B cells are needed for the CD4+ helper
T cell to fully acquire aTfh cell phenotype andmigrate into theGC.
Similarly, upon antigen stimulation, CCR7 expression is increased
on B cells, which consequently migrate to the border of T cell zone
to get T cell help (Nutt and Tarlinton, 2011).
T follicular helper cells are crucial for GC formation and for B
cell responses (Nutt and Tarlinton, 2011). In a recent paper, Tfh
cells were shown to be more susceptible to simian immunodeﬁ-
ciency virus (SIV) infection in vivo (Klatt et al., 2011) than other
CD4+ T cell subsets. The increased number of PCs observed in
lymphoid tissues of HIV-1 infected patients may also lead to Tfh
cell defects as a role of PCs in inhibiting Tfh cell functions was
described (Pelletier et al., 2010). It remains essential to establish to
which extent Tfh cells are affected in vivo during HIV-1 infection,
as their altered functions could explain the dysregulations of GC
reaction observed in patients. We previously showed that CXCR5
expression is altered onB cells fromHIV-1 infected patients,which
togetherwith increased levels of circulatingCXCL13, the ligand for
CXCR5,might lead to impaired follicularmigration of B and other
cells (Cagigi et al., 2008). Surprisingly B cells also produceCXCL13
during HIV-1 infection. It is interesting to speculate on the pos-
sibility that increased production of CXCL13 from B cells may
affect the follicular localization of Tfh cells, a process mediated by
up-regulationof CXCR5 receptor onTfh cells (Haynes et al., 2007).
PD-1 BLOCKADE MAY LEAD TO INCREASE PRODUCTION OF
ANTIBODIES TO PATHOGENS AND VACCINES
The depletion of activatedmemory B cells in blood of SIV-infected
macaques progressing rapidly to AIDS-associated conditions was
associated with lack of development of SIV-speciﬁc Ab responses,
reduction of non-SIV-speciﬁc antibody levels, and appearance of
intestinal bacterial infections (Titanji et al., 2010). Titanji et al.
(2010) suggested that PD-1 expression on B cells may play an
important role in regulating the survival of activated memory B
cells since in vitro blockade of PD-1 improved the survival of acti-
vated memory B cells and in vivo trials in SIV-infected monkeys
showed that PD-1 blockade enhanced antibody responses to SIV
and other microbial pathogens. Although the molecular interac-
tions of PD-1present onB cellswithPD-1 ligands present on either
T or B cells need further characterization, the results presented by
Velu and Titanji pave the way for new therapy intervention during
HIV infection based on PD-1 blockade (Velu et al., 2009; Titanji
et al., 2010).
Molecular contact between PD-1 on T cells with PD-1 ligands
on B cells was shown to positively affect antibody production
through quality regulation of GC reactions and long-lived PC for-
mation (Good-Jacobson et al., 2010).Apoptosis of B cells increased
in GCs in the absence of PD-1 signals resulting in the formation
of lower numbers of long-lived PCs. Interestingly, a recent paper
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FIGURE 1 | Alterations in B cell activation in lymphoid tissues during
HIV-1 infection.TheT cell depletion observed in lymphoid tissues could
prevent efﬁcient B cell activation at the border of T- and B-cell zones. The
infection of T follicular helper (Tfh) cells with HIV-1 may contribute to
decreased IL-21 production and, together with altered expression of
chemokines (CCL19/21 and CXCL13), may further enhance the lack of
germinal center (GC) formation. Follicular dendritic cells (FDC) network is
also reduced during HIV-1 infection. The consequence of these dysfunctions
may ultimately result in the impaired serological memory observed in HIV-1
infected patients. In addition, immune activation and inﬂammation,
pathogenic features of HIV-1 infection, may contribute to B cell polyclonal
activation and accumulation of plasma cells in lymphoid tissues possibly
contributing to hypergammaglobulinemia found in serum of infected
patients.
showed that a population of Foxp3+Blimp-1+CD4+ T cells may
be crucial to control the germinal center response (Linterman et al.,
2011). These follicular regulatory T cells were shown to be a dis-
tinct T cell population sharing phenotypic characteristics with
both Tfh cells and conventional Foxp3+ regulatory T cells, to be
suppressive in vitro and to limit the number of Tfh and GC B
cells. Interestingly, in the absence of Foxp3+Blimp-1+CD4+ T
cells fewer antigen-speciﬁc B cells were found in GCs due to an
expansion of non-antigen-speciﬁc B cells.
The PD-1 blockade trials conducted in the SIV-infected
macaques and the new exciting information on PD-1 role in
controlling GCs may fuel research and intervention to improve
production of pathogen speciﬁc antibody responses in HIV-1
infection.
ALTERATION OF IL-21 PRODUCTION
Secreted by Tfh cells in the lymphoid tissue, IL-21 has a crucial
role in GC formation (Bessa et al., 2010; Zotos et al., 2010) and
induction of B cell differentiation toward PCs from both naïve and
memory B cells (Ettinger et al., 2008). Interestingly, while IL-21
deﬁciency in mice does not impair early memory B cell responses
(Linterman et al., 2010), its presence is important for secondary
immune responses (Rankin et al., 2011). Extra-follicular B cell
responses appear to be IL-21 independent (Linterman et al., 2010).
In humans, IL-21 pathway is involved in long-lived antibody
responses (Avery et al., 2010). Impairment of IL-21 receptor sig-
naling occurs in B cells from individuals with STAT-3 deﬁciency,
leading to a marked decreased of memory B cell formation. IL-21
was also shown to induce the expression of activation-induced
cytidinedeaminase and class-switch recombination (Ettinger et al.,
2005).
Serum IL-21 levels are decreased in HIV-1 infected patients
and a correlation was found between IL-21 levels and CD4+ T
cell counts (Iannello et al., 2008, 2010). Additionally, IL-21 pro-
duction by CD4+ T cells from HIV-1 infected patients has been
associated with a relative control of viral load (Yue et al., 2010).
It would be of great interest to study the impact of HIV-1 infec-
tion on IL-21 production from Tfh as these studies could give a
crucial insight on IL-21 level in lymphoid tissues and its impact
on B cells. It is likely that administration of IL-21 would bene-
ﬁcially impact on the generation of PCs during HIV-1 infection.
Indeed, it was recently shown that IL-21 administration during
SIV-infection leads to higher levels of SIV–antibody and memory
B cells (Pallikkuth et al., 2011).
HYPERGAMMAGLOBULINEMIA: THE ROLE OF
INFLAMMATION
The mechanisms leading to abnormal B cell activation and high
immunoglobulin levels observed in patients are not conclusively
established. In this part, we will focus on the role of immune
activation as a possible mechanism leading to hypergammaglob-
ulinemia.
INFLAMMATION AS RESULT OF MICROBIAL TRANSLOCATION
OCCURRING AT THE DAMAGED EPITHELIAL BARRIER IN THE GUT
DURING HIV-1 INFECTION
The gut-associated lymphoid tissue (GALT) is a site for HIV-
1 replication during the acute and chronic stages of HIV-1
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infection (Mehandru et al., 2004). It was reported that pro-
nounced SIV replication in resting memory T cells in the
gut leads to depletion of CD4+ T cells in the lamina pro-
pria through a Fas–Fas ligand dependent mechanism (Li et al.,
2005). Damage to the gastrointestinal tract during HIV-1 infec-
tion also results in microbial translocation (Brenchley et al.,
2006). Microbial products such as lipopolysaccharide, pepti-
doglycan, and bacterial CpG DNA, can directly stimulate the
innate immune system through toll-like receptors. Epithelial and
supportive cells at the gut barrier are important regulators of
the immune environment; CD4+ T cell depletion, especially
of Th17 cells, has been linked to disruption of the epithelium
(Dandekar et al., 2010). Additionally IL-1β, interferon (IFN)-
γ, and tumor necrosis factor (TNF) expression was signiﬁcantly
increased in GALT during primary HIV-1 infection (Nilsson et al.,
2007). The dysregulated levels of these cytokines in the gut is
likely due to translocation of microbial components through
the gut epithelium (Brenchley et al., 2006) which stimulate
macrophages.
THE IMPACT OF INFLAMMATORY CYTOKINES ON THE EXPRESSION OF
SURVIVAL FACTORS FOR B CELLS AND PLASMA CELLS
It is unclear how the inﬂammatory environment established dur-
ing HIV-1 infection may contribute to changes in the expression
of cytokines and factors produced from stromal cells present in
lymphoid tissue.
Plasma cells reside in the BM next to reticular stromal cells,
which form a survival niche and ensure their long-term survival
(Tokoyoda et al., 2010). In the special microenvironment provided
by reticular stromal cells, PCs produce a large amount of antibod-
ies. PC maintenance in BM niches is under control of survival
factors produced from stromal cells which are not yet completely
deﬁned, but include CXCL12, IL-4, IL-5, IL-6, IL-10, IL-21, the
member of TNF family BAFF (B cell Activation Factor) andAPRIL
(Apoptosis-inducing ligand), and the adhesionmolecules ICAM-1
and VCAM-1 (Tokoyoda et al., 2010; Chu et al., 2011).
We cultured stromal cells in the presence of IL-1β and IFN-γ,
important molecules involved in inﬂammation; the gene proﬁles
of stromal cells cultured upon these conditions (as described in
Thang et al., 2010)were obtained and the results analyzed. Interest-
ingly, the stromal cell expression of several of the factors important
for the survival of PCs is altered after exposure to IL-1β and IFN-γ
(Table 1). For some of the factors, including IL-6, BAFF, ICAM-
1, and VCAM-1 the gene expression was up-regulated more than
10 times. These results suggest that inﬂammation may lead to a
profound deregulation of expression of survival factors for PCs.
INCREASED BAFF AND HYPERGAMMAGLOBULINEMIA
BAFF helps B cells to mature and subsequently ensures their
survival (Brink, 2006; Kalled, 2006). BAFF is produced by
macrophages, dendritic cells, stromal cells, and activated B and
T cells (Kalled, 2006; Mackay and Leung, 2006).
BAFF levels are elevated in HIV-1 infected patients (Stohl et al.,
2002; Rodriguez et al., 2003; Fontaine et al., 2011).When following
patients from primary HIV-1 infection, BAFF levels were shown
to be elevated, in association with increased levels of APRIL, IL-6,
and IL-10 in both rapid and normal HIV-progressors from acute
Table 1 | Gene expression of factors relevant to plasma cell survival
which are produced from stromal cells exposed to IL-1β and IFN-γ.
IL-1β IFN-γ IL-1β+ IFN-γ
CXCL12 −1,64* 1,06 −1,21
IL-4 −1,11 −1,51* −1,53*
IL-5 1,02 −2,10* −2,35**
IL-6 23,44** 2,99** 26,29**
IL-10 −1,12 −1,09 −1,09
IL-21 −1,10 1,04 1,11
APRIL −1,18 1,01 −1,05
BAFF 1,16 15,31** 12,89**
ICAM-1 11,25** 10,62** 43,93**
VCAM-1 3,18* 1,28 32,15**
The gene expression proﬁles of factors relevant to plasma cell survivals changed
upon treatment of HS27 stromal cells for 6 h with IL-1β and/or IFN-γ, as compared
to control cells without stimulation. The numbers in the table indicate the fold
increase in expression levels in the treatment groups versus the control group.
The text in bold indicate signiﬁcant changes. *p<0.05; **p<0.005.The methods
and conditions were previously published (Thang et al., 2010). Brieﬂy, total RNA
was harvested from the HS27 cell line at 6 h after stimulation with either IL-1β or
IFN-γ or the combination of both cytokines; non-stimulated cells (three indepen-
dent cultures for each condition) were used as source for control RNA. Labeled
cDNA was prepared according to standard Affymetrix protocol and hybridized to
the whole-genome microarray Human Gene 1.0 ST (Affymetrix, Inc., Santa Clara,
CA, USA), according to standard Affymetrix protocols. Image analysis was per-
formed using Affymetrix Command Console (AGCC) v 1.1, and the down-stream
processing in Affymetrix Expression Console (EC) v 1.1.
infection into the chronic phase of infection (Fontaine et al., 2011).
BAFF expression remains altered in spite of successful ART; how-
ever in aviremic slow progressors BAFF levels were comparable to
what found in healthy donors. Patients with lower CD4+ T cell
counts display higher BAFF and total IgG levels, suggesting a role
for BAFF in hypergammaglobulinemia (Rodriguez et al., 2003).
In fact, elevated BAFF levels have been linked with increased T-
independentB cell activation and isotype switching inmicemodels
(Mackay and Schneider, 2009). BAFF can also lead to mannose C-
type lectin receptor up-regulation on B cells, facilitating for HIV-1
protein gp120 binding and thus participating in polyclonal B cell
activation occurring in extra-follicular zone of lymphoid tissue
(He et al., 2006).
It can be questioned whether high level of BAFF results from
the pathological immune activation present during HIV-1 infec-
tion in response to the inﬂammatory milieu created by the virus in
lymphoid tissues, including the gut. In support of this hypothesis
it was recently shown that monocytes from patients with sys-
temic lupus erythematosus produced signiﬁcantly larger amounts
of BAFF in response to IFN-γ as compared to healthy controls
(Harigai et al., 2008). It should be further investigated whether this
pathological feature is in common between patients with systemic
lupus erythematosus and HIV-1. BAFF was shown to increase
the chemotactic response of memory B cells toward CXCL13
(Badr et al., 2008). It is yet not studied whether high levels of
CXCL13 (Cagigi et al., 2008) and BAFF may synergize to affect GC
formation.
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CONCLUSION
In summary ﬁbrosis and the altered chemokine and cytokine
levels in lymphoid tissues, together with T cell depletion could
explain some of the impairments of serological memory occurring
in HIV-1 infected patients. Microbial translocation and inﬂam-
mation, which have been previously involved in T cell hyper-
activation and depletion, may be important factors in the dereg-
ulated expression of molecule and pathways involved in B cell
differentiation.
Cellular and molecular studies are essential to pin-point the
exact mechanisms of damaged GC formation during HIV-1 infec-
tion. Many relevant studies recently provided new insights on
molecular players and mechanisms relevant for the GC reaction
and regulation of memory B cell maintenance upon physiological
conditions. These studies may be inspiring and pivotal for under-
standing pathogenic mechanisms during HIV-1 infection and
may lead to new potential targets for improving immunological
responses.
Additionally, studies of pathogenic and non-pathogenic SIV-
infection, distinguished by different levels of immune activation,
could contribute key knowledge on B cell dysfunctions occurring
during HIV-1 infection.
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